A human anti-IL-2 antibody that selectively expands regulatory T cells is developed in this study for clinical applications aiming to mitigate autoimmune and inflammatory disorders and to promote transplant tolerance.
- Eleonora Trotta
- Paul H. Bessette
- Jeffrey A. Bluestone